Scheuplein, F., Renner, F., Campbell, J. E., Campbell, R., Savi, C. D., Eckmann, J., . . . Bischoff, J. R. Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors. Frontiers Media S.A.
Chicago Style (17th ed.) CitationScheuplein, Felix, et al. Evaluation of STK17B as a Cancer Immunotherapy Target Utilizing Highly Potent and Selective Small Molecule Inhibitors. Frontiers Media S.A.
MLA (9th ed.) CitationScheuplein, Felix, et al. Evaluation of STK17B as a Cancer Immunotherapy Target Utilizing Highly Potent and Selective Small Molecule Inhibitors. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.